GlassScriptPhysician profile
Sridhar R Bolla
NPI 1316994148
$28,537.61
in general payments reported to CMS, 2019-2025
88 companies · $4,221 in 2025
The $4,221 reported for 2025 was more than what 80% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,780 · 2020: $1,590 · 2021: $2,758 · 2022: $4,558 · 2023: $4,848 · 2024: $3,783 · 2025: $4,221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Long Term Medical Supply Or Device Loan: $2,266 · Education: $91.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,493.48 |
| Long Term Medical Supply Or Device Loan | $2,266.28 |
| Education | $91.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $4,371.43 | 2019-2025 | Kisqali, Piqray |
| Rigel Pharmaceuticals, INC. | $3,836.41 | 2019-2023 | Tavalisse, Rezlidhia |
| E.R. Squibb & Sons, L.L.C. | $1,743.86 | 2019-2025 | Opdivo, Reblozyl, Opdualag |
| Astrazeneca Pharmaceuticals LP | $1,118.43 | 2019-2025 | Lynparza, Enhertu, Imfinzi |
| Amgen INC. | $1,096.65 | 2019-2025 | Lumakras, Kyprolis, Blincyto |
| Merck Sharp & Dohme LLC | $1,089.71 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $945.78 | 2019-2025 | |
| Daiichi Sankyo INC. | $929.87 | 2019-2025 | Enhertu, Injectafer |
| Eisai INC. | $912.79 | 2019-2025 | |
| Genzyme Corporation | $893.46 | 2019-2025 | |
| Janssen Biotech, INC. | $835.54 | 2019-2025 | Tecvayli, Darzalex, Talvey |
| Exelixis INC. | $694.90 | 2019-2025 | Cabometyx |
| Incyte Corporation | $662.32 | 2019-2025 | Jakafi, Monjuvi, Niktimvo |
| Celgene Corporation | $650.53 | 2019-2025 | Reblozyl, Opdivo, Pomalyst |
| Genentech USA, INC. | $593.38 | 2019-2025 | Tecentriq, Phesgo, Polivy |
Show all 86 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $502.19 | 2019-2025 | Venclexta |
| Lilly USA, LLC | $467.65 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Seagen INC. | $455.56 | 2020-2023 | Padcev, Adcetris |
| Takeda Pharmaceuticals U.S.A., INC. | $442.29 | 2019-2025 | Fruzaqla, Alunbrig, Iclusig |
| Gilead Sciences, INC. | $342.29 | 2019-2025 | Trodelvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $287.27 | 2019-2025 | Gilotrif |
| Adaptive Biotechnologies Corporation | $263.57 | 2021-2025 | Clonoseq |
| Sanofi-Aventis U.S. LLC | $259.93 | 2021-2022 | |
| Astellas Pharma US INC | $250.39 | 2019-2025 | Xospata, Xtandi, Padcev |
| Regeneron Healthcare Solutions, INC. | $248.85 | 2019-2025 | Libtayo |
| Puma Biotechnology, INC. | $237.00 | 2019-2024 | Nerlynx |
| Pharmacyclics LLC, An Abbvie Company | $235.83 | 2019-2023 | Imbruvica, Epkinly |
| Janssen Pharmaceuticals, INC | $227.52 | 2019-2024 | Xarelto |
| Pharmacosmos Therapeutics INC. | $190.31 | 2021-2025 | Monoferric |
| Jazz Pharmaceuticals INC. | $179.91 | 2021-2025 | |
| Acrotech Biopharma INC. | $166.97 | 2022-2023 | Beleodaq |
| Array Biopharma INC | $149.86 | 2022-2025 | Braftovi, Mektovi, Lorbrena |
| Glaxosmithkline, LLC. | $147.98 | 2021-2025 | Ojjaara, Zejula |
| Servier Pharmaceuticals LLC | $147.69 | 2021-2025 | |
| Pharmaessentia USA Corporation | $146.56 | 2022-2025 | Besremi |
| Kite Pharma, INC. | $140.84 | 2022-2024 | Yescarta |
| Coherus Oncology, INC. | $130.86 | 2021-2024 | |
| Clovis Oncology, INC. | $121.66 | 2019-2020 | |
| Beigene USA, INC. | $118.17 | 2020-2022 | |
| Adc Therapeutics America, INC. | $116.56 | 2021-2025 | |
| Mirati Therapeutics, INC. | $114.28 | 2023 | Krazati |
| Alexion Pharmaceuticals, INC. | $112.40 | 2021-2025 | Ultomiris |
| Emd Serono, INC. | $104.72 | 2023-2025 | Tepmetko, Bavencio |
| Foundation Medicine, INC. | $98.58 | 2020-2023 | Foundationone Cdx |
| Bayer Healthcare Pharmaceuticals INC. | $96.88 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $96.09 | 2020-2023 | Tazverik |
| Taiho Oncology, INC. | $94.44 | 2022-2025 | |
| Morphosys, US INC. | $91.08 | 2021-2023 | Monjuvi |
| Karyopharm Therapeutics INC. | $86.55 | 2020-2023 | Xpovio |
| Tersera Therapeutics LLC | $75.97 | 2023-2024 | Zoladex, Xermelo |
| Syndax Pharmaceuticals, INC. | $73.75 | 2025 | Revuforj |
| Global Blood Therapeutics, INC. | $68.63 | 2021-2022 | |
| Stemline Therapeutics INC. | $66.44 | 2022-2024 | Orserdu |
| Agios Pharmaceuticals, INC. | $64.57 | 2022-2023 | Pyrukynd |
| Genmab U.S., INC. | $60.93 | 2022-2025 | Epkinly |
| Tg Therapeutics, INC. | $60.22 | 2022 | |
| Geron Corporation | $52.75 | 2025 | Rytelo |
| Blueprint Medicines Corporation | $52.30 | 2024-2025 | Ayvakit |
| Dova Pharmaceuticals | $47.79 | 2019-2021 | |
| Kyowa Kirin, INC. | $45.59 | 2021-2024 | Poteligeo |
| Teva Pharmaceuticals USA, INC. | $38.97 | 2019-2021 | |
| Epizyme, INC. | $36.92 | 2021 | |
| Octapharma USA, INC. | $35.75 | 2023 | Octagam Immune Globulin (Human) |
| Beone Medicines USA, INC. | $32.98 | 2025 | Brukinsa |
| Sobi, INC | $30.79 | 2023-2025 | |
| Organon LLC | $30.09 | 2023 | Ontruzant |
| Corcept Therapeutics | $29.46 | 2025 | Korlym |
| Cti Biopharma Corp. | $29.09 | 2022 | |
| Deciphera Pharmaceuticals INC. | $26.99 | 2022 | |
| Mylan Institutional INC. | $25.55 | 2020 | |
| Macrogenics, INC. | $24.86 | 2022 | |
| Iovance Biotherapeutics, INC. | $24.84 | 2025 | Amtagvi |
| Nestle Healthcare Nutrition INC. | $24.78 | 2022 | |
| Novocure INC. | $23.56 | 2024 | Optune Lua (Novottf-200t) |
| Immunocore Limited | $23.25 | 2024 | Kimmtrak |
| Tolmar Pharmaceuticals, INC. | $20.93 | 2022 | |
| Eli Lilly and Company | $20.16 | 2019 | |
| Sun Pharmaceutical Industries INC. | $19.97 | 2024 | |
| Acceleron Pharma, INC. | $19.08 | 2020 | |
| Apellis Pharmaceuticals, INC. | $17.67 | 2023 | Empaveli |
| Helsinn Therapeutics (U.S.), INC. | $15.86 | 2019 | |
| Shield Therapeutics INC | $14.63 | 2025 | |
| Verastem, INC. | $14.28 | 2019 | |
| Tactile Systems Technology INC | $13.65 | 2019 | |
| Immunomedics, INC. | $13.48 | 2020 | |
| Springworks Therapeutics, INC. | $13.29 | 2024 | Ogsiveo |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Kisqali $2,294Keytruda $639Lenvima $534Opdivo $530Reblozyl $496Lynparza $429Cabometyx $378Enhertu $353Jakafi $232Adcetris $208Xtandi $205Padcev $203Tecvayli $184Fruzaqla $183Elrexfio $176Lutathera $170Scemblix $169Clonoseq $152Darzalex $149Injectafer $145Welireg $145Venclexta $144Braftovi $137Mektovi $137Talzenna $130Epkinly $130Zepzelca $127Inlyta $119Jaypirca $118Monjuvi $118Fabhalta $117Krazati $114Pluvicto $109Piqray $108Tibsovo $107Trodelvy $106Talvey $106Monoferric $103Lorbrena $102Libtayo $101Sarclisa $101Imbruvica $100Udenyca $95.04Xalkori $91.29Jevtana $91.26Besremi $90.87Orgovyx $90.45Promacta $89.17Tecentriq $86.71Xospata $84.55Ibrance $78.07Lonsurf $75.88Revuforj $73.75Niktimvo $73.39Alunbrig $71.61Beleodaq $71.29Imfinzi $68.49Lumakras $66.90Phesgo $63.68Tasigna $59.74Yescarta $59.43Paxlovid $59.09Gilotrif $58.62Opdualag $58.31Comirnaty $55.54Verzenio $53.59Xpovio $52.95Rytelo $52.75Ayvakit $52.30Zoladex $51.58Ultomiris $47.22Iclusig $46.90Erleada $46.80Polivy $46.79Pyrukynd $44.26Orserdu $44.26Bosulif $43.70Calquence $42.83Tepmetko $42.42Carvykti $41.51Kyprolis $41.40Xarelto $40.93Tabrecta $40.42Retevmo $40.08Tagrisso $38.49Rozlytrek $37.72Alecensa $37.72Gavreto $37.72Rezlidhia $36.83Tavalisse $36.83Octagam Immune Globulin (Human) $35.75Ojjaara $35.68Mekinist $34.97Lunsumio $33.20Brukinsa $32.98Bavencio $32.65Rybrevant $31.77Doptelet $30.79Ontruzant $30.09Korlym $29.46
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sridhar Bolla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.